Powered by: Motilal Oswal
2025-06-30 04:55:26 pm | Source: Prabhudas Lilladher Capital Ltd
Perspective on Markets 30 June 2025 by Mr. Vikram Kasat, Head - Advisory, PL Capital
Perspective on Markets 30 June 2025 by Mr. Vikram Kasat, Head - Advisory, PL Capital

Below the Perspective on Markets 30 June 2025 by Mr. Vikram Kasat, Head - Advisory, PL Capital

 

“Indian benchmark indices ended lower on Monday, weighed down by losses in financials and auto stocks, even as global cues remained broadly supportive. The Sensex closed 468 points lower at 82,139, while the Nifty slipped 155 points to end at 25,463.

 

Key movers included:

- Torrent Pharma jumped 4% after announcing a ?11,900 crore acquisition of JB Chemicals.

- Alembic Pharma surged over 13% after securing USFDA approval for an injectable drug.

- CarTrade Tech and Narayana Health gained more than 6%.

- Karnataka Bank fell over 8% following the resignation of its MD & CEO.

Pharma and PSU banking stocks provided some support, while broader markets fared better—mid and small-cap indices closed with modest gains of up to 0.5%.

 

Bottom line: Despite a positive global setup and renewed FII interest, domestic markets remain under pressure due to profit booking and sector-specific weakness.

What to watch this week: Markets will track June auto sales data, Q1 pre-earnings commentary, global oil price movements, and FII activity, which could steer near-term direction.”

 

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here